JEFFRY GOLD: Open Payments
NPI 1598141236 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$456 in 29 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $26 · 2025 $456
Food & beverage: $456
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $215 |
| Phathom Pharmaceuticals, Inc. | 11 | $89 |
| Madrigal Pharmaceuticals | 2 | $73 |
| Ardelyx, Inc. | 2 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| GENZYME CORPORATION | 1 | $21 |
Products named: VOQUEZNA, REZDIFFRA, LINZESS, CREON, SKYRIZI, IBSRELA, ENTYVIO, DUPIXENT.
Industry payments across FL — which companies pay providers there.
